REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > 1-thia-4-aza-bicyclo (3.2.0) Heptane Ring Containing (including Dehydrogenated) (e.g., Penicillins, Etc.) 1-thia-4-aza-bicyclo (3.2.0) Heptane Ring Containing (including Dehydrogenated) (e.g., Penicillins, Etc.)1-thia-4-aza-bicyclo (3.2.0) Heptane Ring Containing (including Dehydrogenated) (e.g., Penicillins, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/30/06 - 20060270648 - Use of polyamines with antibiotics Compositions and methods for affecting antibiotic resistance, for improving the overall efficacy of antibiotics, and for killing bacteria are included herein involving the use of polyamines to sensitize bacteria and resistant bacterial strains to hydrophilic antibiotics and to reduce bacterial resistance to such antibiotics. ... 11/30/06 - 20060270647 - Glutamate agents in the treatment of mental disorders Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator ... 10/19/06 - 20060234995 - Compositions containing piperacillin and tazobactam useful for injection An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferably citrate, and optionally an aminoglycoside. The product may be in the form of a frozen composition that ... 09/28/06 - 20060217361 - Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors The present invention provides a compound of formula I, pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof. ... 08/03/06 - 20060172987 - Amoxicillin trihydrate The present invention relates to a product of amoxicillin trihydrate, having a free water content of less than 0.1 wt. %, preferably less than 0.07 wt. %, more preferably less than 0.05 wt. %, measured at an equilibrium relative humidity of 30% and at a temperature of 25° C. The ... 07/27/06 - 20060166958 - Crystalline amoxicillin trihydrate powder The invention relates to crystalline amoxicillin trihydrate powder having a bulk density higher than 0.45 g/ml. The invention also relates to a process for preparing crystalline amoxicillin trihydrate powder, said process comprising: crystallizing amoxicillin trihydrate from a solution containing dissolved amoxicillin; separating the crystals from said solution; and drying the ... 06/08/06 - 20060122164 - Carboxylic acid esters of pharmaceutical compounds A pharmaceutically active compound having a carboxylic acid group —COOH as a part of its chemical structure which —COOH group is in the form of a carboxylic acid ester. ... 04/20/06 - 20060084639 - Compositions containing piperacillin and tazobactam useful for injection The invention provides a pharmaceutical composition comprising piperacillin, tazobactam, an aminocarboxylic acid, and a buffer in a sodium lactate diluent. The invention further relates to a method of treating a bacterial infection and an LR condition in a human which comprises administering to said human an effective amount of a ... 04/13/06 - 20060079496 - Agglomerates by crystallisation The present invention describes novel agglomerates in crystalline form of β-lactum compounds, Furthermore, a process for the preparation of said agglomerates, wherein a solution or suspension of at least one β-lactum compound in a solvent is mixed with one or more anti-solvents has been described. ... 04/06/06 - 20060074064 - Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors The present invention provides a compound of formula I, pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof. ... 03/16/06 - 20060058280 - Preparation of penicillin procaine A process for preparing penicillin G procaine comprises the steps of introducing inactive ingredients into a first mixing tank and sterilising the mixture of inactive ingredients in the first mixing tank. A procaine hydrochloride is dissolved in a second mixing tank, and the contents of the second mixing tank are ... 01/12/06 - 20060009442 - Process for producing carbapenem compound for oral administration In the formulae (1) and (2), R1 denotes a hydrogen atom, a trimethylsilyl group or a triethylsilyl group; R2 denotes an alkyl group having 1 to 10 carbon atoms or a cycloalkyl group having 3 to 10 carbon atoms; R3 denotes an organic group; and R4 denotes hydrogen, a trimethylsilyl ... 11/24/05 - 20050261267 - Pharmaceutical formulation Pharmaceutical formulations comprising amoxycillin and clavulante in a ratio of from 10:1 to 20:1 are of use in the emperic treatment of infections potentially caused by DRSP. ... 11/03/05 - 20050245498 - Sterically-awkward beta-lactamase inhibitors Sterically-awkward 6-β-substituted P-lactam compounds as inhibitors of β-lactamase activity, such compounds as can be used in conjunction with one or more β-lactam antibiotics in a system for treatment of a β-lactam resistant bacterial infection. ... 08/04/05 - 20050171077 - Compositions containing piperacillin and tazobactam The invention pertains to pharmaceutical compositions of Zosyn® having substantially free or reduced levels of galactomannan and processes to prepare said pharmaceutical compositions. ... 07/07/05 - 20050148571 - Method of treating bacterial infections using gemifloxacin or a salt thereof and a betha-lactam antibiotic The present invention relates to a method of treating anti-bacterial infections which method comprises the separate, simultaneous or sequential administration to a patient in need thereof, of an effective amount of gemifloxacin or a salt thereof and a β-lactam antibiotic. ... 07/07/05 - 20050148570 - Novel substituted alkane compounds and uses thereof The present invention includes compounds, methods of making the compounds, compositions including the compounds and/or use of the compounds and compositions, wherein the compounds of the following formulas ... 06/23/05 - 20050137181 - Method for treatment of reactive arthritis or bursitis A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the tetracycline family, and a member of the nitroimidazole family, or alternatively, ... ### FreshPatents.com Support |